🌅 Pre-Market Pulse

S&P Futures
7,459.00
▲ +21.75 (+0.29%)
Nasdaq Futures
28,640.25
▲ +154.25 (+0.54%)
Dow Futures
52,159.00
▲ +262.00 (+0.50%)
10Y Treasury
4.70%
▲ +0.05%
US Dollar
101.39
▼ -0.02 (-0.02%)
Bitcoin
$64,954
▼ -$97 (-0.15%)
Data as of 7:06 AM ET
Good morning! Friday is looking like a decent way to close out the week, with all three major futures contracts pointing higher heading into the open. The S&P 500 is up about a third of a percent in pre-market trading, the Nasdaq is leading the charge at plus 0.54%, and there is no shortage of corporate headlines to chew through before the bell. From oilfield services beats to pharma stumbles and a fresh EU smackdown on TikTok, this morning has a little something for everyone. Here is what matters heading into Friday's session.

👀 What to Watch Today

The earnings calendar remains the primary driver of price action today, with several sector-level stories demanding attention. SLB (SLB) already dropped its Q2 results overnight and cleared the bar, offering a useful read-through for the broader energy services space. Traders will be watching how energy stocks react when the market opens, particularly given the company's commentary around Middle East softness.

On the macro side, keep an eye on Treasury yields after a modest overnight rise pushed the 10-year to 4.70% and the 30-year to 5.17%. That kind of creep in long-duration rates tends to pressure growth names, so watch the Nasdaq's ability to hold its pre-market gains once cash trading begins. The Dollar Index (DXY) slipping slightly to 101.39 is a mild tailwind for multinational earnings.

Consumer sentiment and any Fed speaker commentary scheduled for Friday could add a late-session catalyst. With equities grinding higher through July, any fresh macro data that challenges the soft-landing narrative will get amplified attention.

🌏 Overnight Recap

European markets absorbed a batch of corporate news overnight, with AstraZeneca (AZN) shares sliding after a rare clinical trial failure rattled confidence in the pharma giant. CEO Pascal Soriot has built one of the most impressive track records in the sector over 14 years, so a high-profile stumble like this draws outsized attention. The miss is worth watching for ripple effects across the broader biopharma space during Friday's session.

Volkswagen (VWAGY) added another layer of pressure to the European auto sector, cutting its 2026 sales outlook after a rough second quarter. The company now expects sales to fall by as much as 3%, which is not exactly the confidence boost a sector already dealing with EV transition headwinds needed. Ford (F) also faces its own domestic headaches, with a recall of more than 565,000 U.S. vehicles announced over engine compartment fire risks.

In the regulatory lane, EU officials formally charged ByteDance's TikTok with breaching online safety rules related to children, a development that keeps the platform's operational future in Europe uncertain. That is a macro overhang for the broader digital advertising ecosystem, even if no single U.S.-listed stock takes a direct hit at the open.
Sponsored Content

AI Breakthrough Could Soon Reorder Stock Market Winners and Losers

Featured image
For years, we've been led to believe the tech firm operating at 500 Howard Street in Silicon Valley is "one of the good guys." But will the advanced form of AI that just emerged from this location change the way we live, work and invest forever? Marc Chaikin reveals the time-sensitive details of this discovery and offers you a FREE 3-part playbook to protect your future.

📊 Pre-Market Movers

SLB is getting positive attention in pre-market trading after its Q2 earnings beat, with steady demand across core markets helping the oilfield services leader absorb Middle East softness. It is a clean beat in a sector that has been navigating choppy macro waters, and it sets a constructive tone for energy services names heading into Friday.

On the downside, AstraZeneca (AZN) is the name to watch for selling pressure after the trial failure news hit overnight. The stock has been a long-term outperformer under CEO Pascal Soriot, so any meaningful pullback could attract dip buyers, but the initial read is negative. Merck (MRK) is in a different kind of spotlight after announcing voluntary licensing deals with seven generic drug makers to produce a once-monthly oral HIV pill across 129 lower-income countries. That is a goodwill headline that may not move the stock dramatically but reinforces MRK's pipeline depth.

Reckitt (RBGLY) confirmed it is selling its Russian hygiene business to Arnest Management, continuing its strategic portfolio cleanup. No price tag was disclosed, which keeps the market guessing on the financial impact.

🔍 Today's Watchlist

  1. SLB: Watch for energy sector sympathy moves after the oilfield services leader beat Q2 estimates overnight
  2. AZN: AstraZeneca shares sliding pre-market after a clinical trial failure, monitor biopharma peers for contagion
  3. F: Ford faces recall headlines on 565,000 vehicles, watch for consumer sentiment impact on auto names
  4. 10-Year Treasury at 4.70%: Rising yields could cap Nasdaq upside despite strong futures heading into the open
  5. TikTok EU ruling: Regulatory pressure on ByteDance could spark broader conversation around platform risk for digital ad stocks
Sponsored Content

The Energy Stock Trump Once Called "A Big Mistake" to Mess With

Featured image
When a U.S. ally tried to tax ONE American energy company... Trump didn't hesitate to issue a direct warning. Now this same company is generating over $3 billion in operating income... And partnering with the hottest AI stock on Wall Street. Out of 23,281 publicly traded stocks, this is the ONLY one that meets all the "unicorn" criteria.

🎯 The Morning Playbook

Friday's setup is constructive but not without its complications. Futures are green across the board, earnings are flowing in at a steady clip, and the dollar is behaving. The tricky part is that rising Treasury yields and a pair of negative corporate stories out of Europe could test the bulls once cash trading starts.

The smart focus today is on earnings quality over quantity. SLB's beat tells you demand in energy services is holding, but the VW outlook cut and AZN's trial stumble are reminders that not every Q2 story is a winner. Keep position sizing disciplined heading into the weekend, especially with yields at these levels.

Markets have shown genuine resilience through July, and nothing in this morning's tape breaks that story. But the weekend is approaching, and traders who lock in gains early on Friday have a habit of looking pretty smart by Monday morning. Stay sharp and have a great close to the week.

🔍 Hand-Picked for You

Is This Elon Musk's Next IPO?
Is This Elon Musk's Next IPO? (Ad)

After taking SpaceX public in the biggest IPO ever, Elon Musk is already working with a NEW startup that's growing faster than Tesla… Faster than SpaceX… And faster than any of Elon Musk's previous ventures. Bloomberg has just confirmed that this startup is moving towards "a blockbuster IPO." And Je...

Click here to get the name completely free of charge…

Trump's Favorite AI Energy Stock??
Trump's Favorite AI Energy Stock?? (Ad)

It's wildly profitable - Over $3 billion in operating income. It has a partnership with the hottest AI stock on Wall Street. And Trump has publicly backed it?

Get the details on #1 AI energy stock here.

Trump Admin to Pump $1 Billion into this
Trump Admin to Pump $1 Billion into this "Off-the-Radar" AI Stock (Ad)

The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into MP Materials. The stock popped 200%. It bought 10% of Trilogy Metals. The stock popped 500%. And now, Trump has chosen this AI stock for a $1 billion payday.

Click here for the full story and stock pick (free).
Financial Edge Daily SMS
Your Phone Is Smarter Than Your Inbox

Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.

Text Me the Alerts

Keep Reading